chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3rd dose of the COVID-19 vaccine on 13APR2021 and the 4th dose on 10MAY2021; mildly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (3rd dose of the COVID-19 vaccine on 13APR2021 and the 4th dose on 10MAY2021) and MYALGIA (mildly sore arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder NOS (Blood condition). Concomitant products included ATORVASTATIN, MAGNESIUM OXIDE, FISH OIL, MINERALS NOS, VITAMINS NOS (CENTRUM JR [MINERALS NOS;VITAMINS NOS]), PANTOPRAZOLE, FINASTERIDE, TAMSULOSIN, AMLODIPINE, FERROUS SULFATE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (mildly sore arm). On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (3rd dose of the COVID-19 vaccine on 13APR2021 and the 4th dose on 10MAY2021). On 12-Feb-2021, MYALGIA (mildly sore arm) had resolved. At the time of the report, EXTRA DOSE ADMINISTERED (3rd dose of the COVID-19 vaccine on 13APR2021 and the 4th dose on 10MAY2021) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Antibody test: negative (Negative) Spike protein antibody test was negative on Mar-2021.. In June 2021, Antibody test: negative (Negative) Spike protein antibody test was negative on Jun-2021..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided.   This case was linked to MOD-2021-237330, MOD-2021-238101 (Patient Link).
This is a spontaneous report from a non-contactable consumer (the patient). A 24-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 24, via an unspecified route of administration, in the right arm, on an unknown date, in Feb 2021, single dose, for COVID-19 immunisation. No medical history or concomitant medications reported. The patient has no known allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date in Feb 2021, patient experienced mild acne breakouts on upper back and chest. Since the vaccination, patient has not tested for COVID-19. The outcome of mild acne breakouts on upper back and chest: unknown (at the time of report). No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.
tingling; itchy rash; chills; fever; diarrhea; weight loss; This case was reported by a consumer via call center representative and described the occurrence of tingling in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th January 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 21st January 2021, 1 days after receiving Shingrix, the patient experienced itchy rash, chills, fever, diarrhea and weight loss. On 22nd January 2021, the patient experienced tingling. On an unknown date, the outcome of the tingling and itchy rash were not recovered/not resolved and the outcome of the chills, fever and diarrhea were recovered/resolved and the outcome of the weight loss was unknown.   The reporter considered the tingling to be related to Shingrix. It was unknown if the reporter considered the itchy rash, chills, fever, diarrhea and weight loss to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient herself. The patient received 2nd dose Shingrix in left arm and 2 days after the vaccination patient had tingling. The patient also experienced itchy rash, chills, fever, diarrhea and weight loss. The patient stated most side effects mentioned started on Thursday and most of them resolved but the weight loss and the tingling not resolved, and the rash was better but not completely gone. The reporter consented to follow up.
Pt possibly received normal saline diluent instead of the Pfizer vaccine. There was an error in preparation. Pt was contacted on 2/16/21. No adverse reaction reported.
Sitting down in recliner on 2/3/19 at 4:00pm, vision started going blurry and then felt like she was going to faint. This went on for several minutes. This feeling gradually went away.  She did not feel good for about a week after vaccination.
First started feeling upset stomach and severe headache, then a couple hours later, the body aches and joint pain set in. He said his lower body felt like he'd been in a car accident. He couldn't keep anything down to take pain medicine all day long so was miserable all day until about 4pm when he was able to drink some water and take some Vicodin, which did not help. He was up and down all night long with the headache and body aches, and I gave him Excedrin about 6am and that finally started alleviating the headache. He took it again at 11am and was able to eat then, and is gradually been feeling better throughout the day. He was finally able to take his regular meds so now the body aches have subsided (48 hours after injection/36 hours after onset of symptoms).
The day after the vaccine, I started getting strong skin sensitivities on my left hip and groin areas. It lasted for 3 1/2 weeks.  It felt like when I touched these areas even slightly, it was very sensitive (kind of like neuritis). I could feel it even when these areas weren't being touched. I was also very weak feeling especially in the mornings, for about 2 1/2 weeks following the vaccine, like my knees were going to buckle from under me if I was standing or walking. I couldn't drink coffee during this time because it seemed to make it worse. Also, for the last 5 months since the vaccine, it seems I has increased joint pains.
Chest pain; Headache; Fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 61-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Tromethamine, reaction(s): "GI bleeding". Vaccination history included: Bnt162b2 (Dose: 1 lot number FJ8762), for COVID-19 immunization, reaction(s): "Chest pain", "headache", "fever". The following information was reported: CHEST PAIN (non-serious), outcome "unknown"; HEADACHE (non-serious), outcome "unknown"; PYREXIA (non-serious), outcome "unknown", described as "Fever". Additional information: The patient was going for her pre-registration last month for the vaccination, she saw tromethamine listed as part of the bivalent vaccine. She and her mom have a reaction to tromethamine. "If I take tromethamine orally, I'll have GI bleeding. For her (mom), she gets very ill whether she gets it orally or through IV". They both had Pfizer vaccines each time because "Moderna had tromethamine as ingredient from the very beginning." They had a mild reaction to the previous Pfizer vaccine they had. LOT#FJ8762. Caller wants to know if there is a way to trace if the Pfizer vaccine they had contained tromethamine as they were able to "tolerate it". The information will help her decide if they should get the bivalent vaccine. For me, I had chest pain, headache, fever for my vaccines".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Some induration at injection site but not terse. Skin with no increased warmth and skin not tender to touch. Looks like local reaction not cellulitis.
Information has been received from a physician concerning a 13 year old female who on 22-DEC-2008 was vaccinated with her first dose of GARDASIL (lot number, route and site not reported). On 22-DEC-2008 the patient was vaccinated with her second dose of GARDASIL (lot number 661766/0652X, route and site not reported) 0.5 ml. There was no concomitant medication. On 23-FEB-2009 after receiving the second dose, the patient fainted. On 23-FEB-2009 the patient recovered from fainting. Additional information has been requested.
Near Syncope Seen by EMT on site  Discharged home with father at 1750
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 16-SEP-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J001700 and expiry date: 08-MAY-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
28 year old healthy male had contact with a military vaccinee 5/15/03. Vaccinee vaccinated 1 month prior to contact. 1st lesion on mid-back/thorax 5/9/03. 2nd lesion 5/12/03. 3rd digit left hand with multiple on face. Patient evaluated at medical center. Sent to specialist for DFA/viral checkup at public health lab.
Got Td 7/6/04 in left arm, seen again in office on 7/10/04 with left arm swelling and warmth also with tenderness. 1.5 in diameter redness. Warmth= 1+. Tx: Keflex 500 mg BID
Patient had passed out and had woken back within minutes. Patient requested coke and water. She waited in the vaccine area until she felt better and was able to walk and leave store.
15 y/o female clinic visit for update in vaccines received MENACTRA/Hep A/varicella vaccines before (+) pregnancy test.  Date of visit was 8/26/08.
Felt cold at 4pm 3/8 Sore arm  Had a fever of 100.3 F at 4pm 3/9 Felt fine 3/10
Severe chills - 2 AM woke up shaking uncontrollably. Husband added 5 blankets and heating pad. Took 2 Tylenol and large glass of water - had hydrated well on Friday. No fever. Still having intermittent chills, clammy skin, sweating, trouble concentrating, headache, tired but those seem to be normal. Had delta Covid-19 the last week of September 2021 thru 1st week of October. Had fever a full 2 weeks, loss of appetite, slept all the time, very weak, and trouble with concentration. Not sure if I should get the next shot or which one if so.
dizziness; Weakness; Anxious; This spontaneous case was reported by a non-health professional and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (Weakness) and ANXIETY (Anxious) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), ASTHENIA (Weakness) and ANXIETY (Anxious). At the time of the report, DIZZINESS (dizziness), ASTHENIA (Weakness) and ANXIETY (Anxious) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication provided no treatment taken
Woke on the morning of 11/30 with inability to grip and weakness in feet. Progressed through day leading to fall. Referred to the Medical Center ER where I was admitted and diagnosed with Guillian Barre syndrome. Hospitalized for one week and transferred to Rehabilitation. Released 12/19/18. Continues to have pain and discomfort in feet and toes as of 11/21/19.
4 to 5 hrs following vaccine injection, patient developed severe chills, B.P. plummeted, temp. spiked to 104 degrees - 105 degrees. Emerg. transport to E.R. Once stabilized was admitted to CCU. Suffered a set back. Treated for septic shock, Congestive Heart Failure, pneumonia, etc. Hospital 13 days - P.T. 9 days.
I did not have any side effects from the vaccines itself just arm pain. I had a break-through COVID-19 case. I had a runny nose, sore throat, and fever 102. I called my PCP the next day and she wanted me to come in to test for COVID-19, the test came back positive. My PCP put me on some medicine (promethazine & benzonatate) but she did send me to get the antibody infusion and started feeling better immediately. My symptoms started to resolve after that. I also got a line/dent in my thumbnail that appeared when I got COVID-19, I still have it but it's getting better.
In addition to the normal flu like symptoms that are typically reported, I had a reaction in my Right Eye.   I saw Flashes of light and it felt like I was punched in the eye.  After about a week of discomfort, the eye started to feel better, but I now have a floating "floater" in my eye when look up and down.  It is particularly noticeable when driving during bright light.
This spontaneous report was received from a physician via company representative and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions or concomitant therapies were not reported. On 03-OCT-2014, the patient was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 lot # K004148, expiration date 10-MAY-2015 (route was not reported). This vaccine was improperly stored exposed to temperature excursion for a sum of 72 hours at a lowest temperature recorded of 34 degree F (1.11 degree C), and for a sum of 24 hours at a highest temperature recorded of 47 degree F (8.33 degree C). No adverse effects were reported. There was no product quality complained involved. This is one of several reports received from the same reporter. Additional information has been requested.
Nurse documented that Hepatitis A adult dose was given when a pediatric/adolescent dose should have been administered.
Head cold; Scratchy throat; Sneezing; Runny nose; Soft stools; Stuffy head; blowing nose; Kind of Foggy/Fuzzy; Achy; cheeks would ache my ears would feel achy; Headache; Chills that did not last long; Low grade fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and FAECES SOFT (Soft stools) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A/OJ4C1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), FAECES SOFT (Soft stools), HEAD DISCOMFORT (Stuffy head), NASAL CONGESTION (blowing nose), FEELING ABNORMAL (Kind of Foggy/Fuzzy), PAIN (Achy), EAR DISCOMFORT (cheeks would ache my ears would feel achy), HEADACHE (Headache), CHILLS (Chills that did not last long), PYREXIA (Low grade fever) and MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, NASOPHARYNGITIS (Head cold), THROAT IRRITATION (Scratchy throat), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), FAECES SOFT (Soft stools), HEAD DISCOMFORT (Stuffy head), NASAL CONGESTION (blowing nose), FEELING ABNORMAL (Kind of Foggy/Fuzzy), PAIN (Achy), EAR DISCOMFORT (cheeks would ache my ears would feel achy), HEADACHE (Headache), CHILLS (Chills that did not last long), PYREXIA (Low grade fever) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low (Low) Low grade fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information was not reported. Treatment  information also include Neti pot.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow up information received on 01-jul-2021 contains significant follow up.
STOMACH UPSET; MIGRAINE; VOMITING; FEELING WEAK; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 04-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 04-MAR-2021, the subject experienced stomach upset. On 04-MAR-2021, the subject experienced migraine. On 04-MAR-2021, the subject experienced vomiting. On 04-MAR-2021, the subject experienced feeling weak. On 04-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from migraine, vomiting, feeling weak, and fever, and had not recovered from stomach upset. This report was non-serious.
After arriving home from getting my vaccination in my left arm, I experienced pain in my right arm (non in the left arm) and the pain continued resonating down into my right foot. Then I have a very strange rash on my left shoulder. I have the red rash on my left arm in the area of where my shot was given.
Had a rash with blisters over some parts of body. Temp. of 101 degrees on Friday night. Then rash over body. Mom gave tylenol for fever,gave baths with baking soda for itching.
Sore arm, fever, body aches, chills, nerve pain, night sweats (3 night).  Couldn't sleep. Had to take Oxycodone. Changed body chemistry. Arm pit  order- onion/garlic smell (two weeks)
PATIENT COMPLAINED OF RASH /HIVES ON NECK AND BACK, NO SOB OR WHEEZING.  PATIENT SAID SHE TOOK BENADRYL BUT NO RELIEF.
Pt called 1 hour post-injection c/o scratchy throat and chest pain. Pt instructed to call 911. Will follow up tomorrow.
Intense itching at injection site; Slight swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Intense itching at injection site) and VACCINATION SITE SWELLING (Slight swelling at injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Intense itching at injection site) and VACCINATION SITE SWELLING (Slight swelling at injection site). At the time of the report, VACCINATION SITE PRURITUS (Intense itching at injection site) and VACCINATION SITE SWELLING (Slight swelling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.  The patient reported that it was annoying, like an insect bite.
pt recv 1st vax;3jun94,pt devel an "exaggerated,local immun rxn" w/ swelling,redness & 15x8cm abscess at inject site;tenderness under arm w/diff raising arm;T 102;to er;abscess was 6x10;to MD w/granulation tissue from wound cauterized;recv
Symptoms of nausea, tiredness, and headache.  Still occurring two days later.  Taking Tylenol for headache.
L arm red and itching 2 days after flu shot received. c/o some dizziness, cough, flu body aches. Has not been in clinic before today because of flu like symptoms. Dr. suggested benadryl cream and warm soaks. Advised to go to PMD if conditon worsens.
one dose of GARDASIL 9 was administered to an unspecified pregnant patient on an unspecified date; No adverse effects reported; This spontaneous prospective pregnancy report was received from a physician and refers to a pregnant female patient of unknown age. There was no information concerning the patient's pertinent medical history, concurrent conditions, concomitant medications, drug reactions or allergies provided. On an unknown date, the patient became pregnant. The last menstruation period (LMP) and estimated delivery date (EDD) were not known. The outcome of the pregnancy was pending.  On an unknown date, the pregnant patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9)(exact dose, route of administration, injection site, lot# and expiration date were not provided) for prophylaxis.  There were no adverse effects reported. The causality assessment was not provided.
Feeling of Dizziness and Disoriented. Woke up with the severe urge to vomit. When trying to get to the bathroom I could not walk or see clearly. And heart rate dropped in high 40s as well as blood sugar dropped in 50s. I had previously went in to hospital for headaches and tension due to a minor electric bike accident and a CT w/o contrast came back normal on 9/25/2021 the on 9/29/2021 a CT with contrast was done so damage to right distal artery. These symptoms may have been from minor electric bike incident but not 100% sure. Prescribed meclizine, lipitor, and aspirin
Red strip at injection site around arm. Warm to touch. Painful. Lasted 2 weeks.
Fever- low grade 100.4, muscle aches, chills, fatigue, headache lasting about 8 hours
soreness in the back and pelvic area; the second shot was more painful than the first injection; chills; extreme fatigue , felt with no energy; Rash on the left arm (which was the arm of the injection); nausea; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness in the back and pelvic area), VACCINATION SITE PAIN (the second shot was more painful than the first injection), CHILLS (chills), FATIGUE (extreme fatigue , felt with no energy) and VACCINATION SITE RASH (Rash on the left arm (which was the arm of the injection)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced MYALGIA (soreness in the back and pelvic area), VACCINATION SITE PAIN (the second shot was more painful than the first injection), CHILLS (chills), FATIGUE (extreme fatigue , felt with no energy), VACCINATION SITE RASH (Rash on the left arm (which was the arm of the injection)) and NAUSEA (nausea). At the time of the report, MYALGIA (soreness in the back and pelvic area), VACCINATION SITE PAIN (the second shot was more painful than the first injection), CHILLS (chills), FATIGUE (extreme fatigue , felt with no energy), VACCINATION SITE RASH (Rash on the left arm (which was the arm of the injection)) and NAUSEA (nausea) outcome was unknown.            No concomitant medications were provided by the reporter.  No treatment details were provided.
Pt had nausea 2.5h s/p injection. Following day had vertigo and mild upper resp symptoms.
states chronic pain in right shoulder "like bursitis" and can't lift over heard or vacuum and such. some days hurt worse than others but pain is there all the time.
pt recvd flu vax & arm felt hot to the touch, & a 3 inch area of induration & redness devel;
Local reaction immunization site 4cm redness and induration within minutes of Varivax dose, treated w/oral Benadryl and cool compress